Mike is Foundation Professor of Oncology and Honorary Consultant Physician at the University of Hull and Hull & East Yorkshire Hospitals NHS Trust. His major research interests include lung, breast, and soft tissue sarcoma and the development and testing of new drugs for the treatment of malignant disease.
Lynn has established a programme of cancer research covering histology, molecular pathology, molecular genetics and proteomics at Castle Hill Hospital, Hull. Her main focus is the study of anticancer therapies.